Digital Therapeutic System for Inhibiting Axial Myopia Progression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating myopia, especially in children and adolescents, lack effective and reliable therapeutic options to inhibit the progression of axial myopia, with existing treatments like atropine and special lenses having limitations such as side effects and limited clinical applications.
Innovation Solution
A digital therapeutic system that includes a digital apparatus and application providing eyeball exercise instructions, generated based on neurohumoral factors and a therapeutic hypothesis, to improve eyesight and inhibit axial myopia progression, featuring modules for eye exercises, light therapy, and adherence tracking, integrated with healthcare provider and administrative portals for personalized treatment plans.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If atropine is used to treat myopia, then myopia progression is inhibited, but pupil dilation causes serious dazzling
Solution Approach 1:
The patent extracts the therapeutic effect of atropine (inhibition of myopia progression) while eliminating its harmful side effect (pupil dilation causing dazzling) by using a digital therapeutic approach that targets axial length growth through eye exercises and light therapy without affecting pupil size
2Reliability
If special lenses (dream lens) are used to treat myopia, then myopia progression is inhibited, but corneal damage risk limits clinical applications
Solution Approach 1:
The patent replaces the mechanical/optical intervention of special contact lenses with a digital therapeutic system consisting of eye exercises and light therapy, eliminating the risk of corneal damage while maintaining treatment efficacy for inhibiting myopia progression
3Adaptability or versatility
If existing eye exercise methods are sold without clinical verification, then market availability increases, but therapeutic reliability remains insufficient
Solution Approach 1:
The patent performs preliminary clinical verification and validation of the eye exercise program before market release, establishing therapeutic efficacy through systematic testing and validation, thereby ensuring reliability while maintaining market availability
Solution Approach 2:
The patent incorporates feedback mechanisms through adherence tracking and progression monitoring to continuously validate and optimize the therapeutic effect, ensuring clinical reliability while the program is available in the market
Data Source
AI summary
Systems and methods for improving an eyesight of a subject are provided. A system may include a digital apparatus, which may include a digital instruction generation unit configured to generate one or more digital therapeutic modules for improving the eyesight based on a mechanism of action (MOA) in and a therapeutic hypothesis for improving the eyesight, generate specified digital instructions based on the one or more digital therapeutic modules and provide the digital instructions to a first user, and an outcome collection unit configured to collect the first user's execution outcomes of the digital instructions. The system may also include a healthcare provider portal for a healthcare provider to manage their patients and/or an administrative portal.